Akynzeo is a medicine used to prevent nausea (feeling sick) and vomiting in adults with cancer who are receiving chemotherapy (medicines to treat cancer). Some chemotherapy is known to induce severe nausea and vomiting, and Akynzeo is used in patients receiving either highly emetogenic (vomit-inducing) chemotherapy containing the cancer medicine cisplatin, or other chemotherapies that are moderately emetogenic. Akynzeo is available as capsules and as a powder to be made up into a solution for injection. It contains the active substances netupitant and palonosetron (capsules) or fosnetupitant and palonosetron (powder).
Therapeutic Indication
### Therapeutic indication Akynzeo is indicated in adults for the: - Prevention of acute and delayed nausea and vomiting associated with highly emetogenic cisplatin based cancer chemotherapy. - Prevention of acute and delayed nausea and vomiting associated with moderately emetogenic cancer chemotherapy.
Therapeutic Area (MeSH)
ATC Code
A04AA
ATC Item
5-羟色胺拮抗药
Pharmacotherapeutic Group
Antiemetics and antinauseants
Active Substance (Summary)
INN / Common Names
EMA Name
Akynzeo
Medicine Name
Akynzeo
Aliases
N/A
